APA (7th ed.) Citation

Zhang, C., Zhu, K., & Ma, X. (2017). Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer letters, 396, 66-75. https://doi.org/10.1016/j.canlet.2017.03.018

Chicago Style (17th ed.) Citation

Zhang, Chun-Lin, Kun-Peng Zhu, and Xiao-Long Ma. "Antisense LncRNA FOXC2-AS1 Promotes Doxorubicin Resistance in Osteosarcoma by Increasing the Expression of FOXC2." Cancer Letters 396 (2017): 66-75. https://doi.org/10.1016/j.canlet.2017.03.018.

MLA (9th ed.) Citation

Zhang, Chun-Lin, et al. "Antisense LncRNA FOXC2-AS1 Promotes Doxorubicin Resistance in Osteosarcoma by Increasing the Expression of FOXC2." Cancer Letters, vol. 396, 2017, pp. 66-75, https://doi.org/10.1016/j.canlet.2017.03.018.